RANI - Rani Therapeutics Holdings - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RANI is currently covered by 6 analysts with an average price target of $13.86. This is a potential upside of $6.71 (93.85%) from yesterday's end of day stock price of $7.15.

Rani Therapeutics Holdings's activity chart (see below) currently has 2 price targets and 16 ratings on display. The stock rating distribution of RANI is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 46 days.

Highest price target for RANI is $17, Lowest price target is $4, average price target is $13.86.

Most recent stock forecast was given by EDWARD NASH from CANACCORD on 27-Mar-2024. First documented stock forecast 24-Aug-2021.

Best performing analysts who are covering RANI - Rani Therapeutics Holdings:

Mitchell Kapoor Andreas Argyrides Geoff Meacham Annabel Samimy Ashwani Verma Edward Nash

Currently out of the existing stock ratings of RANI, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

9

$1.85 (25.87%)

1 months 7 days ago

0/1 (0%)

$5.97 (197.03%)

Buy

12

$4.85 (67.83%)

1 months 9 days ago

0/5 (0%)

$8.76 (270.37%)

Buy

8

$0.85 (11.89%)

20

2 months 28 days ago

0/3 (0%)

$4.24 (112.77%)

Buy

4

$-3.15 (-44.06%)

15

5 months 19 days ago

1/2 (50%)

$2.01 (101.01%)

146

Buy

24

6 months 2 days ago

1/1 (100%)

$6.24 (35.14%)

65

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RANI (Rani Therapeutics Holdings) average time for price targets to be met?

On average it took 46 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on RANI (Rani Therapeutics Holdings) with a proven track record?

MITCHELL KAPOOR

Which analyst has the current lower performing score on RANI (Rani Therapeutics Holdings) with a proven track record?

EDWARD NASH

Which analyst has the most public recommendations on RANI (Rani Therapeutics Holdings)?

Mitchell Kapoor has 12 price targets and 8 ratings on RANI

Which analyst is the currently most bullish on RANI (Rani Therapeutics Holdings)?

Geoff Meacham with highest potential upside - $9.85

Which analyst is the currently most reserved on RANI (Rani Therapeutics Holdings)?

Ashwani Verma with lowest potential downside - -$3.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?